Detalhe da pesquisa
1.
Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study.
Arthritis Rheum
; 65(9): 2368-79, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23740801